Trifluoroacetate mediated reduction of atherosclerosis in mice

Wei Tang, Audrey S. Black, Romana Moench, Katayoon Marzban, Juan Antonio Raygoza Garay, James J. Zheng, Louis Conway, Antonio F. M. Pinto, Christopher G. Parker, Alan Saghatelian, Luke J. Leman, M. Reza Ghadiri · 2026

Read Trifluoroacetate mediated reduction of atherosclerosis in mice by Wei Tang, Audrey S. Black, Romana Moench, Katayoon Marzban, Juan Antonio Raygoza Garay, James J. Zheng, Louis Conway, Antonio F. M. Pinto, Christopher G. Parker, Alan Saghatelian, Luke J. Leman, M. Reza Ghadiri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13635227.txt.

Description

Tang and colleagues published in twenty twenty-six a mouse study with a surprising result about a common lab chemical. Trifluoroacetate, or TFA, is often treated as a harmless salt partner in made peptides. The team found TFA is in fact active in the body. It changed metabolism in three mouse strains and in cultured liver cells. It also spurred growth of peroxisomes, small cell parts that process fats.

In mice prone to artery plaque and fed a fatty diet, TFA lowered blood fats. Plaque in their arteries also grew less. Evidence pointed to a fat-sensing protein switch as the target. The authors warn that past peptide studies may need a second look. They also note wider questions about TFA exposure in the environment.

Catalog record

CREATORWei Tang, Audrey S. Black, Romana Moench, Katayoon Marzban, Juan Antonio Raygoza Garay, James J. Zheng, Louis Conway, Antonio F. M. Pinto, Christopher G. Parker, Alan Saghatelian, Luke J. Leman, M. Reza Ghadiri
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE132 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13635227

Browse the full library · About the Tower of Babel